Cardiovascular Collapse Secondary to Beta-Blocker Administration in a Setting of Coexisting Thyroid Storm and Atrial Fibrillation: A Case Report
Overview
Affiliations
A thyroid storm is a rare endocrinological emergency caused by severe hyperthyroidism. Reducing circulating levels of free T3 in blood and beta-adrenergic inhibition are the basis of medical treatment for thyroid storms. Propranolol, due to its additional effect of preventing the peripheral conversion of dormant T4 to active form T3, is the chosen drug for blockade in hyperthyroidism and thyroid storm. We describe a rare clinical case of cardiovascular collapse following propranolol administration in a setting of thyroid storm. The patient presented with symptoms of dyspnea and palpitations and had an ejection fraction of 10%. He was started on a calcium channel blocker (diltiazem). Further investigations revealed that the patient also had a thyroid storm and was immediately shifted to methimazole and propranolol. However, following the administration of a beta-blocker, the patient developed circulatory failure as a result of cardiac arrest, necessitating the use of vasopressors and inotropes. This implores the need for further investigations and treatment regimens for cardiovascular conditions, especially atrial fibrillation arising in thyrotoxicosis, as there are no solid treatment guides in the literature to the best of our knowledge.
Thyroid storm in pregnancy: a review.
Vadini V, Vasistha P, Shalit A, Maraka S Thyroid Res. 2024; 17(1):2.
PMID: 38229163 PMC: 10792856. DOI: 10.1186/s13044-024-00190-y.
Elmenyar E, Aoun S, Al Saadi Z, Barkumi A, Cander B, Al-Thani H Diagnostics (Basel). 2023; 13(19).
PMID: 37835772 PMC: 10572182. DOI: 10.3390/diagnostics13193028.
Esmolol Is Not the Solution: Thyroid Storm With Atrial Fibrillation.
Herzallah Z, Gupta S, Abdulhamid M, Muhammed Noori O Cureus. 2023; 15(2):e35201.
PMID: 36960263 PMC: 10031383. DOI: 10.7759/cureus.35201.
Thyrotoxicosis-Induced Cardiogenic Shock: Acute Management Using a Multidisciplinary Approach.
Tolu-Akinnawo O, Abiade J, Awosanya T, Okafor H Cureus. 2022; 14(12):e32841.
PMID: 36570110 PMC: 9779909. DOI: 10.7759/cureus.32841.